Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-15-018528
Filing Date
2015-05-08
Accepted
2015-05-08 16:22:19
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2015 form10q.htm 10-Q 702189
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 139534
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 11909
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12442
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6978
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 7177
  Complete submission text file 0001140361-15-018528.txt   8164910

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rnn-20150331.xml EX-101.INS 1494991
8 XBRL TAXONOMY EXTENSION SCHEMA rnn-20150331.xsd EX-101.SCH 57195
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20150331_cal.xml EX-101.CAL 50550
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20150331_def.xml EX-101.DEF 107711
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20150331_lab.xml EX-101.LAB 356521
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20150331_pre.xml EX-101.PRE 291275
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 15847055
SIC: 2834 Pharmaceutical Preparations